BackExscientia Plc Overview

Exscientia Plc Inventory

Latest inventory for EXAI: $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00
↓ 100.00% YoYΔ $-1.00 vs prior year quarter

Peer trimmed avg / median

Loading

Exscientia Plc Inventory History

Loading

Exscientia Plc vs. peers: Inventory Comparison

Loading

Exscientia Plc Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Exscientia Plc (EXAI) FAQ

As of the most recent data (September 2024), EXAI shows a inventory of $0. That compares with $1 in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EXAI's inventory is now $0 (was $1) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Exscientia Plc is outperforming or lagging.

Tracking EXAI's inventory over time shows whether Exscientia Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1 in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Exscientia Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $0) with ownership activity and broader fundamentals.

Exscientia Plc's inventory is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.